Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer
Titel:
Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer
Auteur:
Trédaniel, J. Barlési, F. Le Péchoux, C. Lerouge, D. Pichon, É. Le Moulec, S. Moreau, L. Friard, S. Westeel, V. Petit, L. Carré, O. Guichard, F. Raffy, O. Villa, J. Prévost, A. Langlais, A. Morin, F. Wislez, M. Giraud, P. Zalcman, G. Mornex, F.